SLI
2.083,81
PKT
-1,26
PKT
-0,06
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.01.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 19.01.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 19.01.24 | Richemont Buy | Deutsche Bank AG | |
| 19.01.24 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.01.24 | Richemont Buy | UBS AG | |
| 19.01.24 | UBS Underweight | Barclays Capital | |
| 19.01.24 | Givaudan Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.01.24 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.01.24 | Richemont Buy | Jefferies & Company Inc. | |
| 18.01.24 | Richemont Outperform | Bernstein Research | |
| 18.01.24 | ams-OSRAM Buy | Deutsche Bank AG | |
| 18.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 18.01.24 | Richemont Buy | UBS AG | |
| 18.01.24 | Richemont Buy | Jefferies & Company Inc. | |
| 17.01.24 | Swiss Re Sell | UBS AG | |
| 17.01.24 | Zurich Insurance Neutral | UBS AG | |
| 16.01.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 16.01.24 | Novartis Buy | Jefferies & Company Inc. | |
| 16.01.24 | Roche Hold | Jefferies & Company Inc. | |
| 16.01.24 | UBS Buy | Goldman Sachs Group Inc. | |
| 15.01.24 | Roche Neutral | UBS AG | |
| 15.01.24 | Novartis Buy | UBS AG | |
| 15.01.24 | UBS Kaufen | DZ BANK | |
| 15.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 15.01.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 15.01.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 12.01.24 | Richemont Buy | Deutsche Bank AG | |
| 12.01.24 | Richemont Buy | Jefferies & Company Inc. | |
| 12.01.24 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 12.01.24 | Richemont Sector Perform | RBC Capital Markets | |
| 12.01.24 | ams-OSRAM Outperform | Bernstein Research | |
| 11.01.24 | UBS Outperform | RBC Capital Markets | |
| 11.01.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 11.01.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 11.01.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 11.01.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 11.01.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 10.01.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 10.01.24 | Nestlé Overweight | JP Morgan Chase & Co. |